Current Assets Endring Dato
AstraZeneca USD 22.5B 338M 2023-09
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Eisai JPY 659.27B 19.2B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Grifols EUR 5.02B 210.6M 2023-09
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06



Infinity Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.